Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
3.970
-0.010 (-0.25%)
Dec 20, 2024, 4:00 PM EST - Market closed

Senti Biosciences Revenue

In the year 2023, Senti Biosciences had annual revenue of $2.56M, down -40.25%.

Revenue (ttm)
$2.56M
Revenue Growth
-40.25%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
48
Market Cap
18.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.56M-1.73M-40.25%
Dec 31, 20224.29M1.53M55.23%
Dec 31, 20212.76M2.20M387.81%
Dec 31, 2020566.00K481.00K565.88%
Dec 31, 201985.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Flora Growth 64.15M
BioLineRx 21.99M
CervoMed 10.07M
Alterity Therapeutics 2.68M
Palatin Technologies 2.38M
Cyclo Therapeutics 870.73K
Revenue Rankings